Malta - English - Medicines Authority

biofarm sp. zo.o walbrzyska str 13, 60-198, poznan, poland - rosuvastatin - film-coated tablet - rosuvastatin 5 mg - lipid modifying agents

Malta - English - Medicines Authority

biofarm sp. zo.o walbrzyska str 13, 60-198, poznan, poland - rosuvastatin - film-coated tablet - rosuvastatin 10 mg - lipid modifying agents

Malta - English - Medicines Authority

biofarm sp. zo.o walbrzyska str 13, 60-198, poznan, poland - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - factor viii inhibitor bypassing activity - powder and solvent for solution for infusion - 1000u (50u/ml)

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

baxter ag - factor viii inhibitor bypassing activity - powder and solvent for solution for infusion - 500u (25u/ml)

European Union - English - EMA (European Medicines Agency)

photonamic gmbh & co. kg - 5-aminolevulinic acid hydrochloride - glioma - antineoplastic agents - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (world health organization grade iii and iv).

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone.in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets.in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).

European Union - English - EMA (European Medicines Agency)

teva b.v.  - oxybutynin - urinary incontinence, urge - urologicals - symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.